BACKGROUND WHO expert groups recommended mortality trials in hospitalized COVID-19 of four re-purposed antiviral drugs. METHODS Study drugs were Remdesivir, Hydroxychloroquine, Lopinavir (fixed-dose combination with Ritonavir) and Interferon-β1a (mainly subcutaneous; initially with Lopinavir, later not). COVID-19 inpatients were randomized equally between whichever study drugs were locally…
AbstractAims. The optimal antithrombotic therapy to balance the risk of thrombosis and bleeding in patients who undergo transcatheter aortic valve implanta
Just under a quarter of a million new cases of lung cancer were diagnosed in 2023, with 10-20% in non-smokers.
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib, according to a retrospective study.
A family history of treatment-resistant depression is a risk factor for resistance to antidepressants.
Treating gum disease soon after catheter ablation to correct atrial fibrillation may lower the risk of recurrence.
Dr. Aaron Goodman joins Dr. Chadi Nabhan to discuss his latest issue with the American Board of Internal Medicine’s Maintenance of Certification program.
A lack of the small protein interferon-β can compromise brain function in patients with HIV.
Softer tumor environments can fuel a more aggressive spread for triple-negative breast cancer.
Prenatal cannabis use disorder increases the risk of neurodevelopmental disorders, such as autism and ADHD, in children.
The use of a 3-dimensional variable flip angle mapping technique is effective in patients with head and neck cancer undergoing CRT.
